Cwestiwn ysgrifenedig WQ91340
- Gofynnwyd gan
- Rhys ab OwenAnnibynnol
- I'w ateb gan
- Minister for Health and Social Services
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 12 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What steps is the Minister taking to ensure that the process of licensing lecanemab and donanemab will be fast and efficient, but not impinge on the safety of patients with Alzheimer’s?
Ateb
Atebwyd gan Minister for Rural Affairs and North Wales, and Trefnydd
Lecanemab and donanemab are not yet licensed for use in the UK. The licensing of medicines is a reserved matter and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).